最新报道:MEI Pharma shifts to a "Lite Strategy" by integrating Litecoin (LTC) for financial transactions and data management, aiming to enhance operational transparency and reduce costs. The company is working with blockchain consultants to develop an implementation framework, with plans to provide further details in its upcoming earnings call. Analysts are divided, citing both innovation potential and cryptocurrency volatility risks.